Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD
Science
OmShanti
December 8, 2020, 6:03am
#1
A positive update from Sage:
3 Likes